David B. Johnston

David B. Johnston, Chief Financial Officer. Dave brings over thirty years of senior financial leadership experience. Currently, he is principal of dbjconsulting llc, providing financial and strategic advice to emerging life science companies. Most recently he was Chief Financial Officer for ImmunoGen, Inc. an oncology focused biotech based in Waltham, MA. During his tenure at ImmunoGen he led several public offerings as well as a creative, non-dilutive royalty financing.

Prior to ImmunoGen, Dave served as CFO for Aveo Oncology and Genzyme Biosurgery where he led both of their initial public offerings as well as leading several strategic initiatives, both on the buy side as well as the sell side.

Mr. Johnston earned a B.S. at Washington and Lee University and an MBA at the University of Michigan. Mr. Johnston sat on the board of directors of RAW Art Works, a nonprofit youth arts organization, as well as Tissue Banks International, one of the largest eye and tissue bank non-profits in the United States.


Copyright 2013-2022 ILiAD Biotechnologies
Financial Conflict of Interest (FCOI) Policy